Merck bets on flu prevention with $9.2 billion deal for Cidara Therapeutics
Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, gaining access to an experimental flu drug in its effort to diversify ahead of patent loss for its
November 14, 2025
All the delicious ways you can reduce food waste in the kitchen
Couple carries on late son's legacy of public service
Tunisia frees prominent lawyer Sonia Dahmani, a critic of the president
Putin sees US peace plan as a starting point as he warns Ukraine's army to withdraw
Putin says it's senseless to sign documents with 'illegitimate' Ukrainian leadership
Dutch prosecutor fines Morgan Stanley 101 million euros for tax evasion
Sally Rooney says UK ban on Palestine Action could force her books off shelves